Sage Journals: Discover world-class research

Abstract

The pars tuberalis (PT) of the pituitary represents an important target site for the time-pacing pineal hormone melatonin because it expresses a large number of mt1 receptors. Functional studies suggest that the PT mediates the seasonal effects of melatonin on prolactin (PRL) secretion. The aim of this study was the characterization of the pheno-type of melatonin-responsive cells. Furthermore, we determined whether RORβ, a retinoid orphan receptor present in the PT, was co-expressed in the same cells. We combined nonradioactive in situ hybridization (ISH) with hapten-labeled riboprobes for detection of the receptors and immunocytochemistry (ICC) for detection of αGSU (α-glycoprotein subunit), βTSH, βFSH, βLH, GH, PRL, and ACTH. Expression of mt1 mRNA was found in small round cells, co-localized with αGSU and βTSH. However, not all βTSH-containing cells expressed mt1 mRNA. The distribution of mt1- and RORβ-positive cells appeared to overlap, although more cells were labeled for RORβ than for mt1. Gonadotrophs, as well as other pars distalis cell types, were never labeled for mt1 melatonin receptor. Therefore, this study identifies the “specific” cells of the PT as the mt1 melatonin receptor-expressing cells.

Keywords

mt1 melatonin receptor RORβ receptor pituitary pars tuberalis in situ hybridization immunocytochemistry

The vertebrate pituitary gland consists of three lobes: the anterior and intermediate lobes, containing hormone-secreting cells, and the posterior neural lobe, containing the axon projections of hypothalamic vaso-pressinergic and oxytocinergic neurons. The latter is connected to the brain by the pituitary stalk. The anterior lobe is subdivided into the pars distalis (PD), which contains the bulk of the hormone-secreting cells, and the pars tuberalis (PT), located rostrally to the PD and extending along the pituitary stalk up to the median eminence. This PT consists of PT-specific secretory cells expressing thyroid-stimulating hormone (TSH), folliculostellate cells, and pars distalis (PD) endocrine cells (expressing pituitary hormones) (Stoeckel et al. 1979; Rudolf et al. 1993; Lin et al. 1994; Sakai et al. 1999). To date, the precise physiological role of this structure is still unclear. In mammals, the PT appears to be a major neuroendocrine target for melatonin because it presents the highest density of melatonin receptors in the brain and endocrine tissues (Williams 1989; Masson-Pevet et al. 1994). Melatonin is a hormone secreted by the pineal gland during the night. Its daily nocturnal signal, which is under the control of the circadian clock located in the suprachiasmatic nuclei (SCN), provides the organism with both a circadian and a seasonal message (Klein and Moore 1979; Sumova et al. 1995). The PT appears to play a major role in mediating some seasonal effects of melatonin on the neuroendocrine system, such as the photoperiodic control of PRL secretion by lactotrophs of the PD (Lincoln and Clarke 1994,1995; Hazlerigg et al. 1996b; Lincoln and Richardson 1998; Morgan 2000; Stirland et al. 2001). Therefore, the PT can be considered as part of the biological timing system. However, the mechanism by which the melatonin signal is decoded within the PT is still unknown.

High-affinity receptors for melatonin have been described using 2-iodo-melatonin as a ligand (Vakkuri et al. 1984). Two high-affinity receptors for melatonin have thus far been cloned in rodents: the mt1 (Mel_1a) and the MT2 (Mel_1b) receptor subtypes (Reppert et al. 1994,1995; Roca et al. 1996) which belong to the seven-transmembrane domain, G-protein-coupled receptor family (Dubocovich et al. 1999). However, the mt1 receptor appears to be the highly dominant subtype in the PT because targeted disruption of its gene in mice leads to undetectable levels of 2-iodomelatonin binding (Liu et al. 1997), whereas cells transfected with the MT2 receptor gene bind this ligand (Dubocovich et al. 1997). Furthermore, the MT2 receptor subtype is naturally nonfunctional in the golden hamster, which is a highly photoperiodic species (Weaver et al. 1996). Therefore, the mt1 receptor subtype appears sufficient to drive the melatonin-induced photoperiodic response. Although many studies have been performed on the circadian and seasonal transcriptional regulation of mt1 receptors in the PT (Gauer et al. 1993; Guerrero et al. 2000; Schuster et al. 2001), the exact cell type expressing this receptor has not yet been identified. Therefore, one aim of this study was the identification of this cell type in the rat by combining the nonradioactive in situ hybridization (ISH) for the mt1 mRNA with immunocytochemistry (ICC) for the different pituitary hormones.

Retinoid orphan receptors (RORα, -β, and -γ) are transcription factors that belong to the nuclear receptor superfamily and act as monomers at a single halfsite (Carlberg and Wiesenberg 1995; Mangelsdorf and Evans 1995). RORα is expressed mostly in peripheral tissues and in the cerebellum (Nakagawa et al. 1997; Dussault et al. 1998), while RORγ is present in skeletal muscle (Hirose et al. 1994). Interestingly, RORβ is expressed only in the central nervous system and in the PT of the pituitary gland. Its expression is particularly strong in components of the mammalian timing system such as the retina, the pineal gland, the SCN, and the PT (Schaeren-Wiemers et al. 1997; Park et al. 1997; Andre et al. 1998), where it displays daily variations (Baler et al 1996; Schaeren-Wiemers et al. 1997; personal observation). Melatonin was initially suggested as the endogenous ligand for these receptors (Becker-Andre et al. 1994; Wiesenberg et al. 1995), but the evidence supporting this hypothesis has since been questioned (Greiner et al. 1996; Hazlerigg et al. 1996a; Schaeren-Wiemers et al. 1997; Bogan et al. 1998). Thus far, the cell type expressing this receptor in the PT has not been identified. Therefore, in addition to the characterization of the cells expressing the mt1 mRNA, this study aimed to investigate whether mt1 and RORβ mRNAs could be co-expressed in the same cells in both the PT and PD.

Materials and Methods

Animals

Adult male and female Wistar rats were housed in a 12:12 light:dark cycle with food and water ad libitum. The animals were sacrificed during the light phase by transcardial perfusion under deep isoflurane anesthesia. Heparin (500 IU, Héparine Choay; Sanofi, Gentilly, France) was injected into the heart just before a PBS wash containing 0.02% diethylpyrocarbonate (DEPC; Sigma, St Quentin Fallavier, France), followed by the fixative (4% paraformaldehyde, 75 mM lysine, 10 mM sodium metaperiodate in 100 mM phosphate buffer, pH 7.4).

The brains were immediately dissected with the pituitary gland attached, blocked into 1-cm-thick slices, and postfixed in the fixative for 2 hr at 4C. They were then rinsed in 50% ethanol and embedded in polyethylene glycol as described by Klosen et al. (1993). Four to 12-μm-thick coronal and sagittal serial sections were cut and were either collected on silane-coated slides or processed as floating sections.

All procedures used in animal experimentation complied with the French National law implementing the European Communities Council Directive 86/609/EEC. All efforts were made to minimize the number of animals used.

In Situ Hybridization

Hapten-labeled (digoxigenin, fluorescein, or biotin) riboprobes with alkaline phosphatase detection were used. Three independent mt1 cDNAs were used: a partial 468-bp rat mt1 cDNA (Reppert et al. 1994), a 1021–bp rat mt1 cDNA (Poirel et al. 2001), and a full-length mouse mt1 cDNA (Roca et al. 1996). RORβ was detected using riboprobes transcribed from a 512-bp partial rat RORβ cDNA (Becker-Andre et al. 1993). For single ISH, the probes were labeled with digoxigenin. For double ISH, melatonin receptor probes were labeled with digoxigenin and RORβ probes were labeled with either fluorescein or biotin. Fluorescein- or biotin-labeled RORβ probes were first validated in single ISH for both sense and antisense probes.

Sense and antisense riboprobes were transcribed in the presence of labeled nucleotides according to standard procedures. The length of the probes was confirmed by formaldehyde-MOPS agarose gel electrophoresis and Northern blotting. Non-hydrolyzed full-length probes were used to ensure maximal specificity.

Polyethylene glycol sections were postfixed for 10 min at room temperature (RT) in 4% phosphate-buffered formaldehyde, rinsed in PBS, and digested for 30 min at 37C with 1–8 μg/ml proteinase K (Roche; Meylan, France) in PBS. Proteinase K digestion was stopped with 2% phosphate-buffered formaldehyde for 5 min on ice. After three rinses in PBS for 10 min each, the sections were acetylated twice for 10 min in 100 mM triethanolamine, 0.25% acetic anhydride. After two 10-min rinses in PBS, the sections were equilibrated in 5 X SSC, 0.05% Tween-20 before hybridization.

Hybridization was performed for 40 hr at 54C with 200 ng/ml labeled sense or antisense probes in 50% formamide, 5 X SSC, 5 X Denhardt's solution, and 500 μg/ml salmon sperm DNA. After hybridization, the probe was washed off in 5 X SSC at RT for 10 min. Stringency rinses were performed six times for 10 min in 0.1 X SSC at 72C. In some experiments, the sections were also treated with RNase (20 μg/ml in 400 mM NaCl, 10 mM Tris-HCl, pH 7.5, 2.5 mM EDTA for 30 min at 37C) either before or after the stringency rinses.

Hapten-labeled bound probes were detected with alkaline phosphatase-labeled sheep anti-digoxigenin antibodies, sheep anti-fluorescein antibodies, or streptavidin (Roche). Alkaline phosphatase activity was detected with bromo-chloro-indolyl phosphate (BCIP) and nitroblue tetrazolium (NBT) in the presence of 5% polyvinyl alcohol (70,000–100,000 MW; Sigma) (De Block and Debrouwer 1993).

For double ISH experiments, both probes were hybridized simultaneously and detected sequentially using BCIP/NBT as the first chromogen. After this first detection, the first anti-hapten antibodies were eluted by incubating twice for 15 min in 100 mM glycine-HCl buffer, pH 2.2, containing 0.1% Tween-20 (Philippe and Pollock 1998). On control sections, the elution was confirmed by the absence of detectable phosphatase activity.

The second probe was detected with peroxidaselabeled streptavidin (Roche), amplified with biotinylated tyramide (TSA; NEN, Boston, MA), and visualized with alkaline phosphatase-labeled streptavidin and Fast Red/naphthol-AS-MX phosphate (Sigma) as chromogen in the presence of 4% polyvinyl alcohol. The Fast Red/naphthol-AS-MX phosphate detection procedure is 10- to 100-fold less sensitive than the NBT/BCIP procedure, thus requiring a previous tyramide amplification. Without this amplification no signal could be obtained with Fast Red for either melatonin receptor probes or RORβ probes.

Immunocytochemistry

ICC was performed using antibodies (obtained from the NIDDK; Dr. F. Parlow) directed against the following pituitary hormones: rabbit anti-rat α-glyco-protein-subunit (αGSU), rabbit anti-rat β-thyroid-stimulating hormone (βTSH), rabbit anti-rat β-follicle-stimulating hormone (βFSH), rabbit anti-rat β-luteinizing hormone (βLH), guinea pig anti-rat growth hormone (GH), rabbit anti-rat prolactin (PRL), and rabbit anti-human adrenocorticotropin (ACTH). For further characterization, we also used a rabbit antibody to the transcription factor Pit-1 (Santa Cruz Technology; Santa Cruz, CA).

The primary antibodies were incubated overnight and detected using biotinylated secondary antibodies and streptavidin-peroxidase conjuate (Roche). Peroxidase activity was detected using amino-ethyl-carbazole (AEC; Sigma) as chromogen.

For combined ISH and ICC, the slides were first hybridized. After visualization of phosphatase activity with NBT/BCIP, the slides were rinsed and selected for double labeling. The slides were rinsed in 95% ethanol for 5 min to elute some background label and to shift the color of the in situ label to blue. The slides were then immunolabeled using the standard protocol described above, with AEC as the chromogen. The absence of interactions between the ISH and the ICC was verified by omission of the primary antibody in the ICC detection. Further tests included ICC on sections that were mock-hybridized to check for antigen inactivation or decloaking by the hybridization procedure.

For the combined ISH and double ICC, the first immunolabel was performed using nickel-diaminobenzidine as chromogen. The antibodies of the first immunolabel were then eluted with 100 mM glycine buffer (pH 2.2) containing 50 mM β-mercaptoethanol to reduce the disulfide links between the light and the heavy chains of the immunoglobulins. After PBS rinses, the second antibody was incubated overnight and detected using the standard protocol described above, with AEC as the third chromogen. The elution of the first sequence of antibodies was verified on control sections by omission of the primary antibody in the second ICC detection sequence.

Results

mt1 Melatonin Receptor Expression

We detected mt1 melatonin receptor expression in the PT of the adenohypophysis, in accordance with previous studies using radioactive ISH (Figures 1A-1D and 2A). All three mt1 probes provided the same labeling pattern, although optimal results were obtained with the 1021-bp rat probe and the full-length mouse probe. The specificity of the ISH was confirmed by the absence of label with sense probes (Figure 2C). Furthermore, the in situ label was obtained at high stringencies (0.1 X SSC, 72C) and resisted RNase digestion.

The labeled cells were small and ovoid, with the nucleus usually located in one end of the cell (Figures 2B, 2D, and 2E). Labeling was restricted to the cytoplasm, although some cells also displayed labeling of a small point-like structure in the nucleus, probably the nucleolus (Figure 2E). Not all cells of the PT were labeled. Although the proportion of labeled cells was very high, especially in the rostral part of the PT, a few nonlabeled ovoid cells could be detected (Figure 2B). We did not observe labeling of small stellate cells, suggesting that only endocrine cells contained the mt1 melatonin receptor. No mt1 melatonin receptor hybridization could be detected in the walls of the blood vessels (Figures 2B and 2E).

Figure 1

Rostrocaudal series of sections through the pars tuberalis (A-D,G,H) and the zonula tuberalis of the pars distalis (E,F,K,L) of the rat, hybridized for mt1 melatonin receptor (A-F) or RORβ receptor (G-L). The sections are from the same animal, at similar levels, although not adjacent. Both receptors display a similar distribution pattern in the pars and zonula tuberalis. Note that the labeled cells in the zonula tuberalis (E,F,K,L) are scattered along the ventral surface of the pars distalis. Bar = 250 μm.

The mt1 melatonin receptor was also expressed in the rostral part of the PD along the ventral surface (Figures 1E and 1F). These scattered cells appeared identical to those of the PT and were sometimes grouped into small clusters. On sagittal sections, mt1 melatonin receptor-expressing cells could be detected from the most rostral part of the PT to the ventral part of the PD (Figure 2A). However, the density of labeled cells appeared to decrease from the rostral to the caudal part, especially in the PD (Figure 2E). No difference was detected between animals sacrificed early or late in the light phase.

Figure 2

(A) Sagittal section of the medial eminence (me) and the pituitary gland of the rat, hybridized for mt1 melatonin receptor. Labeling is detectable along the PT and surrounds the pituitary stalk in the transition towards the pars distalis (pd). No label is detectable in the pars intermedia (pi). 3V, third ventricle. Bar = 250 μm. (B) PT cells located in the lateral area, labeled for mt1 melatonin receptor. Some cells (arrow) are devoid of labeling. (C) Adjacent section to B labeled with mt1 melatonin receptor sense probe. Asterisk indicates a blood vessel identifiable in both sections. (D) PT cells located in the medial area, labeled for mt1 melatonin receptor. In this area the PT is only one to two cells thick. (E) Zonula tuberalis cells, clustered close to portal vessels (pv) and displaying a slightly lighter label for mt1 melatonin receptor than PT cells. Bar = 25 μm.

Co-expression with Pituitary Hormones

All pituitary hormone antibodies used in the study provided specific labeling of their corresponding cell populations in the PD. Only the anti-GH antibody appeared to crossreact slightly with pro-opiomelanocortin (POMC), as could be detected by a slight labeling of the pars intermedia, POMC-containing neurons and nerve fibers in the hypothalmus, and some slightly labeled corticotrophs in the PD (results not shown). No crossreactivity was observed for any of the other antibodies. Immunolabeling of mock-hybridized sections revealed no antigen inactivation nor decloaking for the antibodies tested. Only a reduction in the background label could be detected. Furthermore, no interference between the hybridization and the immunolabeling procedures could be detected.

The pituitary hormones detected in the PT were αGSU, βTSH, βFSH, and βLH, in accordance with previous studies. No labeled cells were observed with antibodies to GH, PRL, or POMC. In αGSU-labeled PT sections, gonadotrophs were usually easily distinguished from TSH-expressing cells by their larger size. A large number of PT cells were immunolabeled and almost all of them were βTSH/αGSU-positive cells, with the FSH/LH-positive gonadotrophs representing only a very small fraction of the PT cells. Furthermore, these gonadotrophs were irregularly distributed throughout the PT, especially from one rat to another.

Co-expression of mt1 melatonin receptor was observed only with βTSH and αGSU (Figures 3A and 3B). The mt1 mRNA was never detected in βFSH-, or βLH-positive cells (Figures 3C and 3D). Not all βTSH-positive cells in the PT showed co-expression with mt1 melatonin receptor (Figures 3B and 3E-3G). The proportion of double-labeled cells decreased towards the caudal end of the PT, while in the rostral part of the PT almost all cells appeared double labeled. In the pituitary stalk, both βTSH single-labeled and mt1/βTSH double-labeled cells were often located around portal vessels (Figures 3G and 3H).

In the PD, the same pattern of co-expression was observed. The mt1 melatonin receptor was present only in a subpopulation of αGSU- and βTSH-positive cells (Figures 4A and 4B). The morphology of the βTSH-positive cells in the ventral part and the rest of the PD differed. Whereas in the ventral PD these cells were small ovoid cells identical to those of the PT, in the rest of the PD the βTSH-positive cells were large, with an angular shape. Furthermore, the small ovoid mt1-positive cells did not express the transcription factor Pit-1, which was present in the large angular thyrotrophs. A third population consisted of some small ovoid TSH-positive cells, which were devoid of mt1 melatonin receptor labeling and which were located among the mt1/βTSH double-labeled cells in the ventral PD. Pit-1 expression was completely absent from this ventral area of the PD (Figure 4A).

RORβ Expression in the PT and PD

A robust and specific signal for RORβ was obtained in the cortex, the suprachiasmatic nucleus, and the thalamus, as previously described by Schaeren-Wiemers et al. (1997) and Park et al. (1997). As for the mt1 melatonin receptor, the specificity of the hybridization signal was confirmed by the absence of labeling by sense probes, the high stringency of the hybridization procedure, and the resistance to post-hybridization RNase digestion. Almost identical results were obtained with all three hapten labels, except that signal-to-noise ratios were optimal for digoxigenin-labeled probes.

In the pituitary, the RORβ expression pattern was identical to that reported by previous studies using radioactive ISH (Park et al. 1997; Schaeren-Wiemers et al. 1997; Andre et al. 1998) (Figures 1G-1J). RORβ expression was strongest in the PT. The labeled cells were small ovoid cells, with some nonlabeled cells scattered among them (Figures 4C and 4D). The density of the RORβ cells was highest in the rostral PT and decreased slightly towards the caudal part.

In the PD, some very slight RORβ expression was detectable throughout the gland. Furthermore, slight labeling was seen in the pars intermedia. However, in the ventral part of the PD, scattered small ovoid cells showed strong hybridization with the RORβ probe. Therefore, the distribution of strong RORβ expression in the rat PT and PD was identical to that observed for the mt1 melatonin receptor.

The only pituitary hormones present in RORβ-positive cells were βTSH and αGSU (Figure 4C). As with the mt1 receptor, βLH and βFSH were absent from the RORβ-expressing cells (Figure 4D).

Co-expression of mt1 melatonin receptor and RORβ in the same cells of the PT and the PD was confirmed by hybridization of adjacent 4-μm sections (not shown) and by simultaneous double ISH (Figures 4D and 4F). We were unable to ascertain whether all cells co-expressed both the mt1 melatonin receptor and the RORβ receptor. The tyramide-amplified Fast Red detection procedure remained less sensitive than the direct NBT/BCIP, thus raising the possibility that the Fast Red procedure was unable to detect some cells that would be positive by the NBT/BCIP procedure. Nonetheless, the majority of the cells displayed labeling for both receptors.

Discussion

We have observed mt1 melatonin receptor expression in a subpopulation of endocrine cells in the PT of the rat. The distribution and morphology of these cells, as well as their content of αGSU and βTSH, identify them as the “specific” cells of the PT (Gross 1983; Stoeckel and Porte 1984; Rudolf et al. 1993; Sakai et al. 1999). However not all the “specific” cells of the PT express the receptor. No mt1 receptor expression was observed in gonadotrophs or follicular cells of the PT.

In the rat, although “specific” cells from the PT express the same hormonal subunits as the classical PD thyrotrophs, both cell types present many morphological and functional differences. Large and angular in the PD, they are small and ovoid in the PT (Figures 4A and 4B; Rudolf et al. 1993; Sakai et al. 1992,1999). Moreover, the transcription factor Pit-1 implicated in βTSH expression in the PD thyrotrophs is absent in the specific cells of the PT (Figures 4A and 4B; Lin et al. 1994; Bockmann et al. 1997; Sakai et al. 1999). Bockmann et al. (1997) have established that PT cells possess neither TRH receptors nor thyroid hormone receptors. Therefore, TSH synthesis and release in these cells are not subject to the classical controls by TRH and T4. Furthermore, the mt1 melatonin receptor mRNA is highly expressed in a large number of PT “specific” cells located in the PT but also in the rostroventral part of the PD, known as the zonula tuberalis in the sheep (Skinner and Robinson 1995), whereas it is never present in the classical thyrotrophs from the PD. Therefore, although they express the same hormones, TSH-immunoreactive cells in the PT and in the PD are not physiologically regulated in the same way. Wittkowski et al. (1988) have shown that the TSH content of PT-specific cells is strongly reduced in Djungarian hamsters subjected to short days compared to long days. Because this effect is prevented by pinealectomy and can be mimicked by injections of melatonin, it appears that melatonin is a major regulator of TSH expression in the PT (Böckers et al. 1995; Bockmann et al. 1996). Our results suggest that these effects could be mediated through the mt1 receptor.

Figure 3

Co-localization of mt1 melatonin receptor (blue label) with pituitary hormones (red label). In the PT, mt1 melatonin receptor is co-localized with βTSH (A) and αGSU (B). Some PT cells are labeled only for αGSU (arrows in B). No co-localization is observed for gonadotropins (C,D). The proportion of mt1/βTSH double-labeled cells decreases from the rostral part (E) of the PT towards the caudal part (F). The specific cells of the PT are often clustered around portal blood vessels (G,H), where βTSH single-labeled cells can also be observed (arrow in H). Bars: A,C = 10 μm; B,D,H = 20 μm.

Figure 4

(A) Zonula tuberalis of the PD. The cells co-expressing βTSH (red label) and mt1 melatonin receptor (blue label), called “specific cells,” are characterized by the absence of the transcription factor Pit-1 (gray nuclear label). Note the absence of Pit-1 expression in the ventral area of the PD corresponding to the zonula tuberalis. (B) PD. Normal thyrotrophs co-express βTSH (red label) and Pit-1 (gray nuclear label) but do not express the mt1 melatonin receptor. Note the angular shape of the cells compared to the oval shape of the specific cells in A. The Pit-1 transcription factor is also expressed by other non-thyrotroph endocrine cells in the PD. (C) The RORβ (blue label) is present in cells expressing βTSH (red label) in the PD. (D) No co-expression is observed between RORβ (blue label) and βLH (red label) or βFSH. (E) Cluster of zonula tuberalis cells expressing the RORβ receptor. (F) Same section as E, showing co-expression of mt1 melatonin receptor (red fluorcent label) in the same cells expressing the RORβ receptor. When superposed on E, the fluorescent granules in F do not coincide with the violet granules in E. Bars = 20 μm.

The best-established effect of melatonin in mammalian PT cells is inhibition of forskolin-induced cAMP synthesis (Morgan et al. 1995; Vanecek and Watanabe 1998). However, this inhibitory effect requires a previous stimulatory input because melatonin alone has no effect on basal cAMP levels. Recent work by von Gall et al. (2002) suggests that this stimulatory input might be adenosine through the adenosine A2b receptor. The nocturnal downregulation of cAMP levels by melatonin sensitizes the A2b receptor.

Melatonin also downregulates the phosphorylation of CREB in ovine PT cells (McNulty et al. 1994). The phosphorylation of CREB in ovine PT cells is regulated through both cAMP-dependent and cAMP-independent mechanisms (McNulty et al. 1996). The same authors have described in vitro a serum-derived factor that provides a cAMP-independent stimulation of CREB phosphorylation, which is sensitive to melatonin. The presence of CRE-like elements in the promoter of both the αGSU and βTSH genes (Kim et al. 1993; Hashimoto et al. 2000) suggests that melatonin may downregulate their expression by the reduction of phosphoCREB levels during the night. However, no data are available on the nycthemeral regulation of either αGSU or βTSH.

In the hamster PT, Messager et al. (1999,2000,2001) have shown that the photoperiod also regulates the amplitude of expression of Per1, an early-response gene also present in the SCN and part of the circadian clock molecular mechanism (Bae et al. 2001; Reppert and Weaver 2001; Zheng et al. 2001). Interestingly, E-Box binding motifs for bHLH transcription factors such as CLOCK and BMAL1, two other clock-related genes, have been found upstream of the αGSU gene (Jackson et al. 1995; Wood et al. 1999). Because several clock-related genes are expressed in the PT of rodents (Messager et al. 1999; and personal observation), it could be hypothesized that the PT contains a slave molecular oscillator that could be reset and synchronized to the environment lighting conditions directly by melatonin action. In such a case, clock genes would constitute a relay for melatonin in mediating output effects, such as acting on thyrotropins.

Our study also demonstrates that mt1 and RORβ receptors are co-expressed in the same cells. Unpublished results obtained in our laboratory show that the daily variations in RORβ mRNA expression in the rat PT depend on the presence of endogenous melatonin. Furthermore, melatonin has been shown to regulate the transcriptional activity of RORα in MCF-7 breast cancer cells (Dai et al. 2001), which are known to express the mt1 melatonin receptor (Ram et al. 2000). Therefore, it is tempting to speculate that RORβ mRNA expression is dependent on melatonin through mt1 melatonin receptors. Melatonin might thus control the transcriptional activity of RORβ receptors, which might then control other downstream genes. However, thus far no response element for RORα or -β has been described or functionally evaluated in αGSU or βTSH genes.

Our results clearly establish the TSH-containing cells as the major cellular target of endocrine regulation by melatonin in the PT. However, the specific cells of the PT constitute only a small fraction of the thryotrophs of the adenohypophysis. Therefore, the photoperiodic downregulation by melatonin of βTSH expression, and possibly secretion, would affect only marginally the total pituitary output of βTSH. Furthermore, no clear effect of either αGSU or βTSH on the PD secretory activity has been demonstrated in the adult. Therefore, the identity of the endocrine-specific product of the PT, called tuberalin (Stoeckel et al. 1994; Morgan et al. 1996), regulated by melatonin receptors in the TSH-containing cells and responsible for the photoperiodic regulation of PRL secretion by the lactotrophs of the PD, remains to be identified.

Footnotes

Acknowledgements

Supported in part by the Institut de Recherche International Servier.

We wish to thank Dr F. Parlow and the National Hormone and Pituitary Program of the NIDDK for the gift of the anti-hormone antibodies, and Drs S. Reppert and I. Wiesenberg for the gift of the mouse mt1 and rat RORβ cDNAs, respectively. We thank Dr J.P. Loeffler for help with Pit-1 detection. The expert assistance of D. Bonn and A. Senser in animal husbandry is gratefully acknowledged.

References

Andre

Conquet

Steinmayr

Stratton

Porciatti

Becker-Andre

(1998) Disruption of retinoid-related orphan receptor beta changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice. EMBO J 17:3867–3877

Bae

Jin

Maywood

Hastings

Reppert

Weaver

(2001) Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 30:525–536

Baler

Coon

Klein

(1996) Orphan nuclear receptor RZR-beta: cyclic AMP regulates expression in the pineal gland. Biochem Biophys Res Commun 220:975–978

Becker-Andre

Andre

DeLamarter

(1993) Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem Biophys Res Commun 194:1371–1379

Becker-Andre

Wiesenberg

Schaeren-Wiemers

Andre

Missbach

Saurat

Carlberg

(1994) Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily [published erratum appears in J Biol Chem 1997;272:16707]. J Biol Chem 269:28531–28534

Böckers

Niklowitz

Bockmann

Fauteck

Wittkowski

Kreutz

(1995) Daily melatonin injections induce cytological changes in pars tuberalis-specific cells similar to short photoperiod. J Neuroendocrinol 7:607–613

Bockmann

Böckers

Vennemann

Niklowitz

Muller

Wittkowski

Sabel

. (1996) Short photoperiod-dependent down-regulation of thyrotropin-alpha and -beta in hamster pars tuberalis-specific cells is prevented by pinealectomy. Endocrinology 137:1804–1813

Bockmann

Böckers

Winter

Wittkowski

Winterhoff

Deufel

Kreutz

(1997) Thyrotropin expression in hypophyseal pars tuberalis-specific cells is 3,5,3′-triiodothyronine, thyrotropin-releasing hormone, and pit-1 independent. Endocrinology 138:1019–1028

Bogan

Cohen

Scanlan

(1998) Natural ligands of nuclear receptors have conserved volumes. Nature Struct Biol 5:679–681

10.

Carlberg

Wiesenberg

(1995) The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: an unexpected relationship. J Pineal Res 18:171–178

11.

Dai

Ram

Yuan

Spriggs

Hill

(2001) Transcriptional repression of RORalpha activity in human breast cancer cells by melatonin. Mol Cell Endocrinol 176:111–120

12.

De Block

Debrouwer

(1993) RNA-RNA in situ hybridization using digoxigenin-labeled probes: the use of high-molecular-weight polyvinyl alcohol in the alkaline phosphatase indoxyl-nitroblue tetrazolium reaction. Anal Biochem 215:86–89

13.

Dubocovich

Masana

Benloucif

(1999) Molecular pharmacology and function of melatonin receptor subtypes. Adv Exp Med Biol 460:181–190

14.

Dubocovich

Masana

Iacob

Sauri

(1997) Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 355:365–375

15.

Dussault

Fawcett

Matthyssen

Bader

Giguere

(1998) Orphan nuclear receptor ROR alpha-deficient mice display the cerebellar defects of staggerer. Mech Dev 70:147–153

16.

Gauer

Masson-Pevet

Skene

Vivien-Roels

Pevet

(1993) Daily rhythms of melatonin binding sites in the rat pars tuberalis and suprachiasmatic nuclei: evidence for a regulation of melatonin receptors by melatonin itself. Neuroendocrinology 57:120–126

17.

Greiner

Kirfel

Greschik

Dorflinger

Becker

Mercep

Schule

(1996) Functional analysis of retinoid receptor beta, a brain-specific nuclear orphan receptor. Proc Natl Acad Sci USA 93:10105–10110

18.

Gross

(1983) Hormone production in the hypophysial pars tuberalis of intact and hypophysectomized rats. Endocrinology 112:733–744

19.

Guerrero

Gauer

Schuster

Pevet

Masson-Pevet

(2000) Melatonin regulates the mRNA expression of the mt(1) melatonin receptor in the rat pars tuberalis. Neuroendocrinology 71:163–169

20.

Hashimoto

Zanger

Hollenberg

Cohen

Radovick

Wondisford

(2000) cAMP response element-binding protein-binding protein mediates thyrotropin-releasing hormone signaling on thyrotropin subunit genes. J Biol Chem 275:33365–33372

21.

Hazlerigg

Barrett

Hastings

Morgan

(1996a) Are nuclear receptors involved in pituitary responsiveness to melatonin? Mol Cell Endocrinol 123:53–59

22.

Hazlerigg

Hastings

Morgan

(1996b) Production of a prolactin releasing factor by the ovine pars tuberalis. J Neuroendocrinol 8:489–492

23.

Hirose

Smith

Jetten

(1994) ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem Biophys Res Commun 205:1976–1983

24.

Jackson

Gutierrez-Hartmann

Hoeffler

(1995) Upstream stimulatory factor, a basic-helix-loop-helix-zipper protein, regulates the activity of the alpha-glycoprotein hormone subunit gene in pituitary cells. Mol Endocrinol 9:278–291

25.

Kim

McClaskey

Bodenner

Weintraub

(1993) An AP-1-like factor and the pituitary-specific factor Pit-1 are both necessary to mediate hormonal induction of human thyrotropin beta gene expression. J Biol Chem 268:23366–23375

26.

Klein

Moore

(1979) Pineal N-acetyltransferase and hydroxy-indole-O-methyltransferase: control by the retinohypothalamic tract and the suprachiasmatic nucleus. Brain Res 174:245–262

27.

Klosen

Maessen

van den Bosch de

Aguilar

(1993) PEG embedding for immunocytochemistry: application to the analysis of immunoreactivity loss during histological processing. J Histochem Cytochem 41:455–463

28.

Lin

Drolet

Rosenfeld

(1994) Pituitary ontogeny of the Snell dwarf mouse reveals Pit-1-independent and Pit-1-dependent origins of the thyrotrope. Development 120:515–522

29.

Lincoln

Clarke

(1994) Photoperiodically-induced cycles in the secretion of prolactin in hypothalamo-pituitary disconnected rams: evidence for translation of the melatonin signal in the pituitary gland. J Neuroendocrinol 6:251–260

30.

Lincoln

Clarke

(1995) Evidence that melatonin acts in the pituitary gland through a dopamine-independent mechanism to mediate effects of daylength on the secretion of prolactin in the ram. J Neuroendocrinol 7:637–643

31.

Lincoln

Richardson

(1998) Photo-neuroendocrine control of seasonal cycles in body weight, pelage growth and reproduction: lessons from the HPD sheep model. Comp Biochem Physiol [C] 119:283–294

32.

Liu

Weaver

Jin

Shearman

Pieschl

Gribkoff

Reppert

(1997) Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19:91–102

33.

Mangelsdorf

Evans

(1995) The RXR heterodimers and orphan receptors. Cell 83:841–850

34.

Masson-Pevet

George

Kalsbeek

Saboureau

Lakhdar-Ghazal

Pevet

(1994) An attempt to correlate brain areas containing melatonin-binding sites with rhythmic functions: a study in five hibernator species. Cell Tissue Res 278:97–106

35.

McNulty

Ross

Barrett

Hastings

Morgan

(1994) Melatonin regulates the phosphorylation of CREB in ovine pars tuberalis. J Neuroendocrinol 6:523–532

36.

McNulty

Ross

Shiu

Morgan

Hastings

(1996) Phosphorylation of CREB in ovine pars tuberalis is regulated both by cyclic AMP-dependent and cyclic AMP-independent mechanisms. J Neuroendocrinol 8:635–645

37.

Messager

Garabette

Hastings

Hazlerigg

(2001) Tissue-specific abolition of Per1 expression in the pars tuberalis by pinealectomy in the Syrian hamster. Neuroreport 12:579–582

38.

Messager

Hazlerigg

Mercer

Morgan

(2000) Photoperiod differentially regulates the expression of Per1 and ICER in the pars tuberalis and the suprachiasmatic nucleus of the Siberian hamster. Eur J Neurosci 12:2865–2870

39.

Messager

Ross

Barrett

Morgan

(1999) Decoding photoperiodic time through Per1 and ICER gene amplitude. Proc Natl Acad Sci USA 96:9938–9943

40.

Morgan

(2000) The pars tuberalis: the missing link in the photoperiodic regulation of prolactin secretion? J Neuroendocrinol 12:287–295

41.

Morgan

Barrett

Hazlerigg

Milligan

Lawson

MacLean

Davidson

(1995) Melatonin receptors couple through a cholera toxin-sensitive mechanism to inhibit cyclic AMP in the ovine pituitary. J Neuroendocrinol 7:361–369

42.

Morgan

Webster

Mercer

Ross

Hazlerigg

MacLean

Barrett

(1996) The ovine pars tuberalis secretes a factor(s) that regulates gene expression in both lactotropic and non-lactotropic pituitary cells. Endocrinology 137:4018–4026

43.

Nakagawa

Watanabe

Inoue

(1997) Prominent expression of nuclear hormone receptor ROR alpha in Purkinje cells from early development. Neurosci Res 28:177–184

44.

Park

Kim

Yoon

Kim

(1997) Distributional characteristics of the mRNA for retinoid Z receptor beta (RZR beta), a putative nuclear melatonin receptor, in the rat brain and spinal cord. Brain Res 747:332–337

45.

Philippe

Pollock

(1998) Sequential in situ hybridization on tissue sections: a novel approach for analyzing co-expression of different mRNAs in a single cell. Technical Tips Online 1(44): T01333

46.

Poirel

Masson-Pevet

Simonneaux

Pevet

Gauer

(2001) The MT1 melatonin receptor mRNA is regulated on a circadian basis in the rat suprachiasmatic nuclei. Proc 31st Annu Meeting Soc Neurosci 2001;184.3

47.

Ram

Yuan

Dai

Kiefer

Klotz

Spriggs

Hill

(2000) Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin. J Pineal Res 28:210–218

48.

Reppert

Weaver

(2001) Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63:647–676

49.

Reppert

Weaver

Ebisawa

(1994) Cloning and characterization of mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13:1177–1185

50.

Reppert

Godson

Mahle

Weaver

Slaugenhaupt

Gusella

(1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melotonin receptor. Proc Natl Acad Sci USA 92:8734–8738

51.

Roca

Godson

Weaver

Reppert

(1996) Structure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptor. Endocrinology 137:3469–3477

52.

Rudolf

Filler

Wittkowski

(1993) Pars tuberalis specific cells within the pars distalis of the adenohypophysis. An ontogenetic study. Anat Anz 175:171–176

53.

Sakai

Inoue

Kurosumi

(1992) Light and electron microscopic immunocytochemistry of TSH-like cells occurring in the pars tuberalis of the adult male rat pituitary. Arch Histol Cytol 55:151–157

54.

Sakai

Sakamoto

Ijima

Matsubara

Kato

Inoue

(1999) Characterization of TSH-positive cells in foetal rat pars tuberalis that fail to express Pit-1 factor and thyroid hormone beta2 receptors. J Neuroendocrinol 11:187–193

55.

Schaeren-Wiemers

Andre

Kapfhammer

Becker-Andre

(1997) The expression pattern of the orphan nuclear receptor RORbeta in the developing and adult rat nervous system suggests a role in the processing of sensory information and in circadian rhythm. Eur J Neurosci 9:2687–2701

56.

Schuster

Gauer

Malan

Recio

Pevet

Masson-Pevet

(2001) The circadian clock, light/dark cycle and melatonin are differentially involved in the expression of daily and photoperiodic variations in mt(1) melatonin receptors in the Siberian and Syrian hamsters. Neuroendocrinology 74:55–68

57.

Skinner

Robinson

(1995) Melatonin-binding sites in the gonadotroph-enriched zona tuberalis of ewes. J Reprod Fertil 104:243–250

58.

Stirland

Johnston

Cagampang

Morgan

Castro

White

Davis

. (2001) Photoperiodic regulation of prolactin gene expression in the Syrian hamster by a pars tuberalis-derived factor. J Neuroendocrinol 13:147–157

59.

Stoeckel

Hindelang

Klein

Poissonnier

Felix

(1994) Expression of the alpha-subunit of glycoprotein hormones in the pars tuberalis-specific glandular cells in rat, mouse and guinea-pig. Cell Tissue Res 278:617–624

60.

Stoeckel

Hindelang-Gertner

Porte

(1979) Embryonic development and secretory differentiation in the pars tuberalis of the mouse hypophysis. Cell Tissue Res 198:465–476

61.

Stoeckel

Porte

(1984) Fine structure and development of the pars tuberalis in mammals. In Motta

Ultrastructure of Endocrine Cells and Tissues. Boston, Martinus Nijhoff, 29–39

62.

Sumova

Travnickova

Peters

Schwartz

Illnerova

(1995) The rat suprachiasmatic nucleus is a clock for all seasons. Proc Natl Acad Sci USA 92:7754–7758

63.

Vakkuri

Leppaluoto

Vuolteenaho

(1984) Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer. Acta Endocrinol (Copenh) 106:152–157

64.

Vanecek

Watanabe

(1998) Melatonin inhibits the increase of cyclic AMP in rat suprachiasmatic neurons induced by vasoactive intestinal peptide. Neurosci Lett 252:21–24

65.

von Gall

Garabette

Kell

Frenzel

Dehghani

Schumm-Draeger

Weaver

. (2002) Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin. Nature Neurosci 5:234–238

66.

Weaver

Liu

Reppert

(1996) Nature's knockout: the Mel1b receptor is not necessary for reproductive and circadian responses to melatonin in Siberian hamsters. Mol Endocrinol 10:1478–1487

67.

Wiesenberg

Missbach

Kahlen

Schrader

Carlberg

(1995) Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res 23:327–333

68.

Williams

(1989) Melatonin-binding sites in the rat brain and pituitary mapped by in vitro autoradiography. J Mol Endocrinol 3:71–75

69.

Wittkowski

Bergmann

Hoffmann

Pera

(1988) Photoperiod-dependent changes in TSH-like immunoreactivity of cells in the hypophysial pars tuberalis of the Djungarian hamster, Phodopus sungorus. Cell Tissue Res 251:183–187

70.

Wood

Dowding

Gordon

Ridgway

(1999) An upstream regulator of the glycoprotein hormone alpha-subunit gene mediates pituitary cell type activation and repression by different mechanisms. J Biol Chem 274:15526–15532

71.

Zheng

Albrecht

Kaasik

Sage

Vaishnav

. (2001) Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 105:683–694

The mt1 Melatonin Receptor and RORβ Receptor Are Co-localized in Specific TSH-immunoreactive Cells in the Pars Tuberalis of the Rat Pituitary

Abstract

Keywords

Materials and Methods

Animals

In Situ Hybridization

Immunocytochemistry

Results

mt1 Melatonin Receptor Expression

Co-expression with Pituitary Hormones

RORβ Expression in the PT and PD

Discussion

Footnotes

Acknowledgements

References